UPDATE: Regeneron Posts Upbeat Q2 Results

By: via Benzinga
Regeneron Pharmaceuticals (NASDAQ: REGN) reported better-than-expected second-quarter results. The Tarrytown, New York-based company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.